Filing Details
- Accession Number:
- 0001645627-17-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-26 12:32:00
- Reporting Period:
- 2017-05-23
- Filing Date:
- 2017-05-26
- Accepted Time:
- 2017-05-26 12:32:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,958,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,959,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,960,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,961,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,962,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,963,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,964,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,965,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,965,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,966,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,967,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,968,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,969,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,970,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,971,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,972,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,973,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,974,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,975,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,976,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,977,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,978,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,979,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,980,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,981,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,982,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,983,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,984,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,985,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-24 | 1,000 | $0.06 | 20,986,249 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
